Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GBA1 Parkinson Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT07011771
What this trial is testing

A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease

Who this might be right for
GBA1 Parkinson Disease
Capsida Biotherapeutics, Inc.
Not applicableEnrolling By InvitationNCT00001215
What this trial is testing

Genetic Studies of Lysosomal Storage Disorders

Who this might be right for
Lysosomal Storage DisordersGaucher DiseaseParkinson Disease
National Human Genome Research Institute (NHGRI) 1,000
Not applicableStudy completedNCT03234478
What this trial is testing

Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers

Who this might be right for
ParkinsonParkinson DiseaseGenetic Predisposition+2 more
Rutgers, The State University of New Jersey 150
Not applicableUnknownNCT06451419
What this trial is testing

Non Motor Symptoms in Glucocerebrosidase-related Parkinson's Disease

Who this might be right for
Parkinson Disease
Juan Pablo Romero. MD, PhD 40
Not applicableStudy completedNCT04101968
What this trial is testing

The GBA Multimodal Study in Parkinson's Disease

Who this might be right for
Parkinson DiseaseGBA Gene MutationGaucher Disease
Pacific Parkinson's Research Centre 30
Testing effectiveness (Phase 2)UnknownNCT06193421
What this trial is testing

High-Dose Ambroxol in GBA1-Related Parkinson

Who this might be right for
Parkinson DiseaseGBA Gene Mutation
Agyany Pharma LTD 40
Testing effectiveness (Phase 2)Study completedNCT05287503
What this trial is testing

Ambroxol as a Disease-modifying Treatment in GBA-PD

Who this might be right for
Parkinson DiseaseGBA Gene Mutation
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 65
Not applicableUnknownNCT06167603
What this trial is testing

Exploring Brain Molecular Imaging and Blood Biomarkers in Subjects With Glucocerebrosidase Mutations: Toward a Precision Medicine Approach to Characterize Parkinson's Disease Clinical Trajectories

Who this might be right for
Parkinson Disease
IRCCS San Raffaele 140
Testing effectiveness (Phase 2)Active Not RecruitingNCT04127578
What this trial is testing

Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)

Who this might be right for
Parkinson Disease
Prevail Therapeutics 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07414290
What this trial is testing

A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R08b in Parkinson's Disease Patients With GBA1 Mutations

Who this might be right for
Parkinson Disease (PD)
Shanghai Vitalgen BioPharma Co., Ltd. 17
Not applicableNot Yet RecruitingNCT07474779
What this trial is testing

Understanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and Neuroimaging

Who this might be right for
Parkinson's Disease (PD)GBA1 Parkinson DiseaseREM Sleep Behavior Disorder (iRBD)
University of Pavia 160
Not applicableStudy completedNCT04268030
What this trial is testing

High Order Spectral Analysis of Local Field Potential Data on a Subgroup of Parkinson's Disease Patients Who Are Carriers of Mutations in the Glucocerebrosidase (GBA) Gene Undergoing DBS Electrode Placement

Who this might be right for
Parkinson Disease
Rush University Medical Center 9